Showing posts with label health. Show all posts
Showing posts with label health. Show all posts

Wednesday, 5 August 2020

ORIGIN OF SARS-CoV-2: NATURAL EVOLUTION ARGUMENT


 SARS-CoV-2There is ongoing debate among policymakers, scientists and the general public about where SARS-CoV-2, the virus that causes COVID-19, came from. While researchers consider bats the most likely natural hosts for SARS-CoV-2, the origins of the virus are still unclear. On May 10 in the journal Current Biology, researchers describe a recently identified bat coronavirus that is SARS-CoV-2’s closest relative in some regions of the genome and which contains insertions of amino acids at the junction of the S1 and S2 subunits of the virus’s spike protein in a manner similar to SAR-CoV-2.

RmYN02

While it’s not a direct evolutionary precursor of SARS-CoV-2, this new virus, RmYN02, suggests that these types of seemingly unusual insertion events can occur naturally in coronavirus evolution, the researchers say.

“Since the discovery of SARS-CoV-2 there have been a number of unfounded suggestions that the virus has a laboratory origin,” says senior author Weifeng Shi, director and professor at the Institute of Pathogen Biology at Shandong First Medical University in China. “In particular, it has been proposed the S1/S2 insertion is highly unusual and perhaps indicative of laboratory manipulation. Our paper shows very clearly that these events occur naturally in wildlife. This provides strong evidence against SARS-CoV-2 being a laboratory escape.”

The researchers identified RmYN02 from an analysis of 227 bat samples collected in Yunnan province, China, between May and October of 2019. “Since the discovery that bats were the reservoir of SARS coronavirus in 2005, there has been great interest in bats as reservoir species for infectious diseases, particularly as they carry a very high diversity of RNA viruses, including coronaviruses,” Shi says. RNA from the samples was sent for metagenomic next-generation sequencing in early January 2020, soon after the discovery of SARS-CoV-2.

Across the whole genome, the closest relative to SARS-CoV-2 is another virus, called RaTG13, which was previously identified from bats in Yunnan province. But RmYN02, the virus newly discovered here, is even more closely related to SARS-CoV-2 in some parts of the genome, including in the longest encoding section of the genome, where they share 97.2% of their RNA. The researchers note that RmYN02 does not closely resemble SAR-CoV-2 in the region of the genome that encodes the key receptor binding domain that binds to the human ACE2 receptor that SARS-CoV-2 uses to infect host cells. This means it’s not likely to infect human cells.

 amino acid

The key similarity between SARS-CoV-2 and RmYN02, is the finding that RmYN02 also contains amino acid insertions at the point where the two subunits of its spike protein meet. SARS-CoV-2 is characterized by a four-amino-acid insertion at the junction of S1 and S2; this insertion is unique to the virus and has been present in all SARS-CoV-2 sequenced so far. The insertions in RmYN02 are not the same as those in SARS-CoV-2, which indicates that they occurred through independent insertion events. But a similar insertion event happening in a virus identified in bats strongly suggests that these kinds of insertions are of natural origin. “Our findings suggest that these insertion events that initially appeared to be very unusual can, in fact, occur naturally in animal beta coronaviruses,” Prof. Shi says.

“Our work sheds more light on the evolutionary ancestry of SARS-CoV-2,” he adds. “Neither RaTG13 nor RmYN02 is the direct ancestor of SARS-CoV-2, because there is still an evolutionary gap between these viruses. But our study strongly suggests that sampling of more wildlife species will reveal viruses that are even more closely related to SARS-CoV-2 and perhaps even its direct ancestors, which will tell us a great deal about how this virus emerged in humans.”

This work was supported by the Academic Promotion Programme of Shandong First Medical University, the Strategic Priority Research Programme of the Chinese Academy of Sciences, the Chinese National Natural Science Foundation, the National Major Project for Control and Prevention of Infectious Disease in China, the High-End Foreign Experts Program of Yunnan Province, the Taishan Scholars Programme of Shandong Province, the NSFC Outstanding Young Scholars, Youth Innovation Promotion Association of CAS, and an ARC Australian Laureate Fellowship.

REFERENCE

1. Cell Press. (2020, May 11). A close relative of SARS-CoV-2 found in bats offers more evidence it evolved naturally. ScienceDaily. Retrieved May 27, 2020 from https://www.sciencedaily.com/releases/2020/05/200511142202.htm

2. Global Biodefense Staff. (2020, May 11).A Close Relative of SARS-CoV-2 Found in Bats Offers More Evidence It Evolved Naturally. Global Biodefense. Retrieved May 27, 2020 from https://globalbiodefense.com/2020/05/11/a-close-relative-of-sars-cov-2-found-in-bats-offers-more-evidence-it-evolved-naturally/

IMAGE GLOSSARY

1. https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.discovermagazine.com%2Fhealth%2Fwhy-bats-are-breeding-grounds-for-deadly-diseases-like-ebola-and-sars&psig=AOvVaw3rDRhWWRsjxKQbv9q9rWc0&ust=1593872479307000&source=images&cd=vfe&v
ed=0CAIQjRxqFwoTCODpp_yjseoCFQAAAAAdAAAAABAJ

2. https://www.google.com/search?safe=active&sa=G&hl=en&tbs=simg:CAESogIJ_15BFLsomtLoalgILELCMpwgaYgpgCAMSKKMBgAaiAcYBmg-CBa0LtwuhAYQGtCeUI4IikyOGIuMrjDraK8QphSIaMLGSF-i1UPDuG1ZIErvB2ycezu1JSAqU_123B3tW_17
sP-FkufOVFgH79w0GJNs-NsQCAEDAsQjq7-CBoKCggIARIEekHmcQwLEJ3twQkajgEKGwoJY2hvY29sYXRl2qWI9gMKCggvbS8wMjB2bAoZCgZib25ib27apYj2AwsKCS9tLzA1aHhmMQoeCgpleWUgc2hhZG93
2qWI9gMMCgovbS8wMjV6cDJzChgKBnNwaGVyZdqliPYDCgoIL20vMDZ5NDcKGgoHZ2xpdHRlctqliPYDCwoJL20vMDNrcG5jDA&sxsrf=ALeKk03UYDUSKR4sjBG5F-qGM9J5hB7fmw:1596287630843&q=sar
s+1+virus+microscope&tbm=isch&ved=2ahUKEwjdj8jpivrqAhUBzDgGHbKOC7UQjJkEegQICBAB&biw=1536&bih=706&dpr=1.25#imgrc=6FZz6ZIKf-13WM

Wednesday, 1 July 2020

SNEEZE AND CANCER TREATMENT ON THE SAME DRUG?


serious skin cancer treatment
Can a very common allergy medicine improve survival among patients suffering from the serious skin cancer, malignant melanoma? A new study from Lund University in Sweden indicates that this may be the case.

Melanoma
     Melanoma is a type of skin cancer that develops when the melanocytes (the cells that give the skin its tan or brown color) start to grow out of control. Melanoma is much less common than some other types of skin cancers. But melanoma is more dangerous because it is much more likely to spread to other parts of the body if not caught and treated early.


Prof. HÃ¥kan Olsson

“Previous studies have shown that the same antihistamines have survival benefits in breast cancer. Now we see the same thing concerning malignant melanoma. However, more research is required to confirm the results,” emphasizes Prof. HÃ¥kan Olsson. He is one of the researchers behind the study, which was recently published in the research journal, Allergy.

In the study, the researchers examined the use of six antihistamines in patients diagnosed with malignant melanoma; desloratadine, cetirizine, loratadine, clemastine, ebastine and fexofenadine.
fexofenadine
clinical registries

They have matched information from three large clinical registries (the prescribed drug registry, cancer registry and cause of death registry) for everyone in Sweden between 2006 and 2014 who received their first diagnosis of skin cancer, a total of 24,562 individuals. Of these individuals, 1,253 were antihistamine users.
Most used desloratadine (395) cetirizine (324), loratadine (251) or clemastine (192).The other antihistamines were used by considerably fewer individuals. The follow-up of individuals was carried out on 31 December 2018.
“We observed improved survival among those who used desloratadine and to a certain extent also loratadine, particularly in the age group 65 and older, when we compared with those who had not used antihistamines. The use of the other antihistamines showed no significant survival effect. The use of desloratadine and loratadine also seemed to reduce the risk of getting a new malignant melanoma,” says Prof. HÃ¥kan Olsson.
“The finding is interesting for a future drug against melanoma and may also help in advanced stages of the disease. In addition, the medicines have virtually no side effects.”The research team is now planning animal experiments and randomized studies in order to understand the mechanisms behind the effect, the appropriate dose and optimum treatment period.
“We are collaborating with researchers in Barcelona and Stockholm. In Lund, we are underway with studies in both animal and human subjects, in which doses of antihistamines will be compared with the patients who do not take antihistamines, in order to measure the treatment effect,” concludes Prof. HÃ¥kan

REFERENCE
1. Lund University. (2020, May 11). Antihistamines may help patients with malignant melanoma. ScienceDaily. Retrieved May 17, 2020 from https://www.sciencedaily.com/releases/2020/05/200511112616.htm
2. Eurekalert. (2020, May 14). “Allergy Medications May Treat Malignant Melanoma Patients”. Medindia. Retrieved May 17, 2020 from https://www.medindia.net/news/antihistamines-may-help-patients-with-malignant-melanoma-194948-1.htm
3. American Cancer Society. (n.d.). “What Is Melanoma Skin Cancer?” Retrieved May 17, 2020 from https://www.cancer.org/cancer/melanoma-skin-cancer/about/what-is-melanoma.html
#references

IMAGE GLOSSARY
1. https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.express.co.uk%2Flife-style%2Fhealth%2F1150640%2Fskin-cancer-signs-melanoma-symptoms-mole&psig=AOvVaw3cXQ_gNh7MKWxIEDPyyQaD&ust=1590677 603838000&source=images&cd=vfe&ved=0CAIQjRxqFwoTCKDN7uWs1OkCFQAAAAAdAAAAABAD
2. https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.miragenews.com%2Fantihistamines-may-help-patients-with-malignant-melanoma%2F&psig=AOvVaw1t_IqokHJMuNxTXfcZ1FO7&ust=1590676358415000&source=i mages&cd=vfe&ved=0CAIQjRxqFwoTCOivw_Ss1OkCFQAAAAAdAAAAABAD
3. https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.shutterstock.com%2Fimage-photo%2Fkyiv-ukrainemay-27-2019-loratadine-medication-1408679642&psig=AOvVaw3B_mEOlpOjRMdWY80TXFef&ust=159067810 7185000&source=images&cd=vfe&ved=0CAIQjRxqFwoTCJDH4Yut1OkCFQAAAAAdAAAAABAX
4. https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.shutterstock.com%2Fimage-photo%2Fkyiv-ukrainemay-25-2019-fexofenadine-medication-1406925812&psig=AOvVaw3B_mEOlpOjRMdWY80TXFef&ust=1590678 107185000&source=images&cd=vfe&ved=0CAIQjRxqFwoTCJDH4Yut1OkCFQAAAAAdAAAAABAc
5. https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.pinterest.com%2Fpin%2F330381322648811707%2F&psig=AOvVaw3B_mEOlpOjRMdWY80TXFef&ust=1590678107185000&source=images&cd=vfe&ved=0CAIQjRx qFwoTCJDH4Yut1OkCFQAAAAAdAAAAABAn
6. https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.news-medical.net%2Fhealth%2FLong-Term-Effects-of-Taking-Allergy-Medications.aspx&psig=AOvVaw3B_mEOlpOjRMdWY80TXFef&ust=1590678107185000&source=i mages&cd=vfe&ved=0CAIQjRxqFwoTCJDH4Yut1OkCFQAAAAAdAAAAABBX

Friday, 29 May 2020

World’s First Saliva Test Detects Hidden Throat Cancer

saliva test

According to American Society of Clinical Oncology, there is an estimated 53,260 adults (38,330 men and 14,880 women) in the United States will be diagnosed with oral and oropharyngeal cancer in the year 2020. Rates of these cancers are more than twice as high in men as in women. Oral and oropharyngeal cancer are the eighth most common cancer among men. The average age of diagnosis is 62. About 25% of cases occur in people younger than 55, but these cancers are rare in children.


Persistent human papillomavirus (HPV) infection

Persistent human papillomavirus (HPV) infection is now the leading cause of cancers in the oropharynx (tonsils and tongue base area of the throat). In what is believed to be a world-first, a simple saliva test developed by Queensland University of Technology (QUT) biomedical scientists has detected early throat cancer in a person who had no symptom and no clinical signs of cancer.

Chamindie Punyadeera

“The series of saliva tests raised the alert and detected an early cancer before the person had any symptoms,” said QUT Faculty of Health’s Associate Professor Chamindie Punyadeera, who, with Dr Kai Tang, developed the test. Professor Punyadeera said the discovery was made during an HPV-prevalence study which included 665 healthy individuals. The incidence of high-risk human papillomavirus (HPV)-driven throat cancers is on the rise in developed countries. Unfortunately, it is often discovered only when it is more advanced, with patients needing complicated and highly impactful treatment options. In the US, HPV-driven throat cancers have surpassed cervical cancers as the most common cancer caused by HPV.  However, unlike cervical cancer, up until now, there has been no screening test for this type of oropharyngeal cancer.


salivary oral rinse sample “To take the test, all the person has to do is give a salivary oral rinse sample. When the test shows HPV-16 DNA, it is repeated and if the presence of HPV-16 is persistent over a period of time we would
be suspicious that there may be underlying cancer. “The person whom we reported in this study had been consistently HPV-16 DNA positive for 36 months, with a steadily rising count of HPV-16 DNA after testing at 6, 12 and 36 months. The patient was found to have a 2mm squamous cell carcinoma in the left tonsil, treated by tonsillectomy. This has given our patient a high chance of cure with very straightforward treatment. Since the surgery, the patient has had no evidence of HPV-16 DNA in his saliva.”

The presence of this pattern of elevated salivary HPV-DNA must be fully evaluated, as it may provide the critical marker for early cancer detection. Professor Punyadeera said this was the first-ever case of histologically confirmed diagnosis of an asymptomatic, hidden throat cancer, diagnosed with a saliva screening test and that wider validation studies are required to confirm this finding.


REFERENCE

1. American Society of Clinical Oncology (2020). Oral and oropharyngeal cancer statistics. Retrieved from
https://www.cancer.net/cancer-types/oral-and-oropharyngeal-cancer/statistics

2. Higuera, V. (2018, August 9).What is throat cancer?. Heartline. Retrieved May 14, 2020 from
https://www.healthline.com/health/cancer-throat-or-larynx

3. Queensland University of Technology. (2020, May 12). World-first saliva test detects hidden throat cancer. ScienceDaily. Retrieved May 14, 2020 from  www.sciencedaily.com/releases/2020/05/200512093950.htm

4. Queensland University of Technology. (2020, May 12).World-first saliva test detects hidden throat cancer. Medicalxpress. Retrieved May 14, 2020 from
https://medicalxpress.com/news/2020-05-world-first-saliva-hidden-throat-cancer.html

IMAGE GLOSSARY

  1.   
    https://www.google.com/url?sa=i&url=https%3A%2F%2Fwwwdocwirenews.com%2Fdocwire-pick%2Fhem-onc-picks%2Fscientists-develop-first-saliva-test-that-detects-throat-cancer-in-asymptomatic-patients%2F&psig=AOvVaw3KPDYoCgZS-H2xpkfLidUe&ust=1589956569970000&source=images&cd=vfe&ved=0CAIQjRxqFwoTCOix3bmtv-kCFQAAAAAdAAAAABAV
  2.   
    https://www.google.com/url?sa=i&url=https%3A%2F%2Ftwitter.com%2FQUT%2Fstatus%2F1144020919498596352&psig=AOvVaw381qzzqMwZ3Qatq1DBEFxG&ust=1589953762276000&source=images&cd=vfe&ved=0CAIQjRxqFwoTCKC55PCtv-kCFQAAAAAdAAAAABAD
  3.    
    https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.qut.edu.au%2Fresearch%2Farticle%3Fid%3D144469&psig=AOvVaw09oZ1bVIxrHd3pIdaHfuHv&ust=1589957292759000&source=images&cd=vfe&ved=0CAIQjRxqFwoTCODQ0dqqv-kCFQAAAAAdAAAAABAa

Tuesday, 25 June 2019

12 lead EKG Pocket Card @ $16.99


A comprehensive field reference for 12 lead EKG interpretation for medical and allied health students. Include valuable reference materials extending from images of various EKG wave forms to methods for identifying different cardiac disorders like bundle branch block, heart blocks etc. Also include information for identifying modes of pacemakers, coronary blood flow and EKG, effects of electrolyte imbalance in EKG.
 Visit - https://aprnworld.com/product/12-lead-ekg-pocket-card/

Advanced Arrhythmia Recognition with CE hours – DVD @$75.00



Advanced Arrhythmia Recognition course in DVD format. Chapters with rich text and images and professional voice over. Easy to follow format. Continuing education hours are awarded for Nurses after taking exam at www.aprnworld.com. Please email to support@aprnworld.com after purchase for enrolling to exam. Contact hours are approved by all state Boards of Registered Nursing in United States.

Visit - https://aprnworld.com/product/advanced-arrhythmia-recognition-ce-hours-dvd/

Wednesday, 22 May 2019

Overview of Basic Mechanisms of Cardiac Arrhythmia






Electrocardiogram is one of the oldest and most widely used diagnostic tool in modern healthcare. It is considered as one of the lifesaving tools across the world. The ability to identify cardiac rhythms and knowing the significance is one of the essential elements of every healthcare professional’s competency. EKG is a representation of electrical activity of the heart. Any changes in normal electrical function of the heart is called arrhythmia. Understanding arrhythmias can be vital in providing appropriate treatment in a timely manner for many critically ill patients in both in hospital and community settings.




Basic arrhythmia recognition training involves understanding the basic concepts of electrocardiogram. Basic cardiac arrhythmia course offered by APRN WORLD®  provide an opportunity for individuals to understand the concepts behind EKG from the simple to complex approach. The individuals will learn about the basic rhythms and their significance during this course. Basic cardiac arrhythmia course offered on an online platform helps the convenient delivery method for individual students. Professionally narrated material with relevant graphics allow students to have a detailed understanding of the basics of cardiac arrhythmia.

APRN WORLD® ’s Basic arrhythmia recognition course will ensure the competency of candidates through a theory and practice exam at the end of the course.

For more information feel free to contact us at:

Address: 3200 Guasti Road, Suite 100 Ontario, California, 91761
Phone: 909-907-4144
Social Media: